Molecular Pharmacology (USA), Ltd. (MLPH)

Market Cap	999.55K +220.0%
Revenue (ttm)	n/a
Net Income	-105.18K
EPS	-0.00
Shares Out	999.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0010
52-Week Range	0.000001 - 0.0097
Beta	-0.49
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MLPH

Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia, Europe, and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops Tripeptofen, an analgesic and anti-inflammatory molecule for the treatment of every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distri...

• Industry: Shell Companies
• Sector: Financials
• CEO: Jeffrey Edwards
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MLPH